Zeng, Guyu
Zhang, Ce
Song, Ying
Zhang, Zheng
Xu, Jingjing
Liu, Zhenyu
Tang, Xiaofang
Wang, Xiaozeng
Chen, Yan
Zhang, Yongzhen
Zhu, Pei
Guo, Xiaogang
Jiang, Lin
Wang, Zhifang
Liu, Ru
Wang, Qingsheng
Yao, Yi
Feng, Yingqing
Han, Yaling
Yuan, Jinqing
Funding for this research was provided by:
National High Level Hospital Clinical Research Funding (2023-GSP-RC-08 & 2023-GSP-QN-26)
National Key Research and Development Program of China (2016YFC1301300 & 2016YFC1301301, 2016YFC1301300 & 2016YFC1301301, 2016YFC1301300 & 2016YFC1301301, 2016YFC1301300 & 2016YFC1301301, 2016YFC1301300 & 2016YFC1301301, 2016YFC1301300 & 2016YFC1301301, 2016YFC1301300 & 2016YFC1301301, 2016YFC1301300 & 2016YFC1301301, 2016YFC1301300 & 2016YFC1301301)
CAMS Innovation Fund for Medical Sciences (2023-I2M-1-002)
Article History
Received: 6 June 2024
Accepted: 13 December 2024
First Online: 23 December 2024
Declarations
:
: The ethical approval of PROMISE study was obtained from the ethical review board of Fuwai Hospital (2017–860). All patients in this study signed the informed consent.
: Not applicable.
: The authors declare no competing interests.